The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Self-citationThe Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610 · cited 1×
“Hypertension and low levels of high density lipoprotein (HDL), the so-called “good” cholesterol, have long been recognized as predictors of CHD risk (Barter et al., 2007), but the NCEP metabolic syndrome definition provided clinicians a useful concept for understanding the association between…”
BackgroundGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,140
Self-citationUse of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Self-citationJeppesen, J. Ø., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 676
Wannamethee, S. G., Shaper, A. G., Lennon, L., & Morris, R. W. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2644 · Cited by 672
Lorenzo, C., Williams, K., Hunt, K. J., & Haffner, S. M. (2007) · Diabetes Care · doi:10.2337/dc06-1414 · Cited by 662
Stroup, T. S., McEvoy, J. P., Swartz, M. S., Byerly, M. J., Glick, I. D., Canive, J. M., McGee, M. F., Simpson, G. M., Stevens, M. C., & Lieberman, J. A. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006986 · Cited by 636
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s042 · Cited by 576
Smith, S. C., Jr. (2005) · The University of North Carolina at Chapel Hill University Libraries · doi:10.17615/x6gg-7674 · Cited by 546
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Self-citationFord, E. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.022 · Cited by 501
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427
Simplified Estimation from Censored Normal Samples
Dixon, W. J. (1960) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177705900 · Cited by 418
The effects of antipsychotic therapy on serum lipids: a comprehensive review
Meyer, J. M., & Koro, C. E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.014 · Cited by 407
Self-citation(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383
De Hert, M. A., van Winkel, R., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., & Peuskens, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.855 · Cited by 314
Meyer, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0509 · Cited by 267
Self-citationSnijder, M., Visser, M., Dekker, J., Seidell, J., Fuerst, T., Tylavsky, F., Cauley, J., Lang, T., Nevitt, M., & Harris, T. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801968 · Cited by 260
Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., & Remington, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901106 · Cited by 254
Houseknecht, K. L., Robertson, A. S., Zavadoski, W., Gibbs, E. M., Johnson, D. E., & Rollema, H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301209 · Cited by 240
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
Bushe, C., & Holt, R. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.47.s67 · Cited by 212
Henderson, D. C., Nguyen, D. D., Copeland, P. M., Hayden, D. L., Borba, C. P., Louie, P. M., Freudenreich, O., Evins, A. E., Cather, C., & Goff, D. C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0905 · Cited by 205
Self-citationBOBES, J., ARANGO, C., ARANDA, P., CARMENA, R., GARCIAGARCIA, M., & REJAS, J. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.09.025 · Cited by 195
High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia
Hägg, S., Lindblom, Y., Mjörndal, T., & Adolfsson, R. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000188215.84784.17 · Cited by 151
Assmann, G., Guerra, R., Fox, G., Cullen, P., Schulte, H., Willett, D. L., & Grundy, S. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.08.045 · Cited by 149
A 4-Fold Risk of Metabolic Syndrome in Patients With Schizophrenia
Saari, K. M., Lindeman, S. M., Viilo, K. M., Isohanni, M. K., Järvelin, M., Laurén, L., Savolainen, M. J., & Koponen, H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0503 · Cited by 146
Guzder, R., Gatling, W., Mullee, M., & Byrne, C. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0063-9 · Cited by 108
Troisi, R. J., Cowie, C. C., & Harris, M. I. (2000) · JAMA · doi:10.1001/jama.284.24.3157 · Cited by 108
Medical Illness and Schizophrenia
Meyer, J. M., & Nasrallah, H. A. (2003) · Medical Entomology and Zoology · Cited by 85
Self-citationLong-Term Changes in Weight and Plasma Lipids during Maintenance Treatment with Ziprasidone
Weiden, P. J., Newcomer, J. W., Loebel, A. D., Yang, R., & Lebovitz, H. E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301482 · Cited by 80
Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
Srisurapanont, M., Likhitsathian, S., Boonyanaruthee, V., Charnsilp, C., & Jarusuraisin, N. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-14 · Cited by 63
Medical Illness and Schizophrenia
Cascella, N. G. (2004) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000144964.83457.32 · Cited by 59
Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine
Henderson, D. C., Copeland, P. M., Borba, C. P. C., Daley, T. B., Nguyen, D. D., Cagliero, E., Evins, A. E., Zhang, H., Hayden, D. L., Freudenreich, O., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0513 · Cited by 56
Self-citationGirman, C. J., Dekker, J. M., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi229 · Cited by 41
Mayer‐Davis, E. J., Levin, S., Bergman, R. N., D'Agostino, R. B., Jr., Karter, A. J., & Saad, M. F. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.185 · Cited by 36
de Vegt, F., Dekker, J. M., Jager, A., Hienkens, E., Kostense, P. J., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (2001) · JAMA · doi:10.1001/jama.285.16.2109 · Cited by 10
Cited by
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
“Approximately one third of patients in CATIE had a constellation of metabolic and cardiovascular risk factors at baseline [93].”
BackgroundInfluentialRummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.012 · Cited by 675
Metadata
- Authors
- Meyer, J. M., Davis, V. G., Goff, D. C., McEvoy, J. P., Nasrallah, H. A., Davis, S. M., Rosenheck, R. A., Daumit, G. L., Hsiao, J., Swartz, M. S., Stroup, T. S., & Lieberman, J. A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 101
- Issue
- 1-3
- Pages
- 273-286
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2004122611
- Cited by
- 286
- References
- 52
- FWCI
- 21.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.